All Substitutes

Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
EMTREO 5GM INJECTION_1
EMTREO 5GM INJECTION_2
EMTREO 5GM INJECTION_3
EMTREO 5GM INJECTION_1
20% Off

Emtreo 5gm Injection

Prescription Required

Salt Composition : Treosulfan

Manufacturer : EMCURE PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: ₹23628
Price : ₹18902
You Save : ₹4726 (20%)

1 Vial(s)

PAP Information :    Buy 10, Get 1 Free. Contact us for latest updates.

Pincode
Delivery By -
Patient Assistance Programs
Know About PAP

Program Overview: EMCURE PHARMACEUTICALS LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Emtreo 5 gm injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 10 vials of Emtreo 5 gm injection, and you will receive 1 free additional vial. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Emtreo Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Treosulfan 5gm from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Emcure can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: EMCURE PHARMACEUTICALS LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Emtreo 5 gm injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase 10 vials of Emtreo 5 gm injection, and you will receive 1 free additional vial. 

Contact us for the latest updates on this exclusive offer.

Eligibility Criteria: To qualify for the Emtreo Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Treosulfan 5gm from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Emcure can avail of it without having to purchase the medication from MrMed.

Introduction to Emtreo 5gm Injection

Emtreo 5gm injection contains the active substance Treosulfan. It is an anti-neoplastic medication belonging to the group called alkylating agents. This medicine is combined with Fludarabine to treat allogeneic hemopoietic stem cell transplant (alloHSCT) in adults with both malignant and non-malignant. In pediatric patients (older than one month), it treats malignant. 

Do not take Emtreo 5gm injection if you are allergic to Treosulfan or its other ingredients. Notify your doctor if you have any infections or disorders with the heart, lungs, liver, or kidney. Before starting the treatment, inform your doctor if you took any live vaccine or have Fanconi anemia (inherited bone marrow failure syndromes) or other DNA breakage repair disorders. This medicine may reduce the blood count (myelosuppression); your doctor will monitor your blood counts and liver enzymes regularly to detect their functions until recovery of the hematopoietic system.

Before taking a Emtreo 5gm injection, notify your doctor if you are pregnant or planning to get pregnant or breastfeeding. Use effective contraception during and after the last dose for six months of the treatment. Tresosulfan impacts fertility impairment if advised not to father a child during and up to 6 months after treatment. In pediatric patients, dermatitis diaper (inflammation of the skin in the diaper area) may occur, so napkins should be changed frequently for 6–8 hours. Contact your doctor for more information.

Uses of Emtreo 5gm Injection

  • Allogeneic hemopoietic stem cell transplant (alloHSCT)

Therapeutic Effects of Emtreo 5gm Injection

Emtreo 5gm is an alkylating agent. Its mechanism is to cause damage to the DNA structure, leading to inhibition of DNA replication and cancer cell death. 

Interaction of Emtreo 5gm Injection with other drugs

Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional and vitamin supplements, vaccines, and herbal products. Certain medications may interact with the effects of Emtreo 5gm and reduce its effectiveness by causing undesirable side effects. 

More Information about Emtreo 5gm Injection

  • Store at 25ËšC, excursions permitted to 15ËšC to 30ËšC.
  • Keep away from pets and children.
  • Do not refrigerate.

How to consume Emtreo 5gm Injection

Emtreo 5gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Safety Advices for Emtreo 5gm Injection

Image Not Available  

Pregnancy

  

Emtreo 5gm is unsafe to use during pregnancy as it may harm the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant or planning for the pregnancy before starting the treatment. 

Image Not Available  

Breast Feeding

  

Breastfeeding is not recommended in Emtreo 5gm patients because it is unknown whether the medicine passes into the breast milk. So, do not breastfeed during the treatment.

Image Not Available  

Lungs

  

Inform your physician about any underlying lung disorders before taking Emtreo 5gm, as this medication should be used cautiously in lung disease patients. Consult your physician before taking this medicine. 

Image Not Available  

Liver

  

Inform your physician about any underlying liver disorders before taking Emtreo 5gm, as this medication should be used cautiously in liver disease patients. Consult your physician before taking this medicine. 

Image Not Available  

Alcohol

  

It is unknown whether consuming alcohol while taking a Emtreo 5gm tablet is safe. Please speak with your physician.

Image Not Available  

Driving

  

While taking Emtreo 5gm, driving or using machines is unsafe because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information. 

Side Effects of Emtreo 5gm Injection

Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.

Serious

  • Decrease in blood cell count
  • Infections
  • Liver vien blockage
  • Lung inflammation

Common

  • Allergic reaction
  • Decreased appetite
  • Headache, dizziness
  • Irregular heartbeat
  • Breathing difficulties Joint pain
  • Increased liver enzymes
  • The lower level of bilirubin

Word of Advice

Men should avoid fathering a child during and up to 6 months after treatment. This medicine is not safe to be used in pregnancy. Consult your doctor for advice. Use effective contraception during and after six months of the last dose. This medicine can cause fertility impairment; consult your doctor for more fertility concerns. Don't splash or spill the medicine anywhere on the skin. In infants under four months, there is a chance of getting a seizure. Hence monitor for nervous disorders and breathing problems. 

FAQs

Q 1. How is Emtreo 5gm dosage determined?

Emtreo 5gm dosage is based on several factors, including the type and stage of the cancer being treated, the individual's overall health, and their response to the treatment.

Q 2. Can Emtreo 5gm cause a lower level of bilirubin?

One of the common side effects of Emtreo 5gm is the lower level of bilirubin. If you experience any side, contact your physician immediately.

Q 3. Why is liver enzyme getting elevated during treatment with Emtreo 5gm?

The reason for this elevation is not completely understood, but it is thought to be related to the drug's effects on certain enzymes involved in liver function. The elevation in liver enzymes is generally mild and temporary and typically resolves on its own or with dose adjustment of the Emtreo 5gm tablet.

Q 4. What if I missed a dose of Emtreo 5gm?

Do not miss your dose. Keep all your appointments with the dosing regularly. If you forget or miss an appointment, inform your healthcare professional and reschedule the dosing.

Q 5. Can I stop taking Emtreo 5gm after I feel better?

Even if you feel better, continue taking doxycycline until the prescription is completed. If you stop using Emtreo 5gm injections too soon or skip doses, your illness may not be entirely treated.

Fact Box of Emtreo 5gm Injection

Molecule name: Treosulfan

Therapeutic class: Antineoplastics 

Pharmacological class: Alkalyting agent

Indications:  Allogeneic hemopoietic stem cell transplant (alloHSCT)

References

  1. Medexus Inc., [Revised on 25th Jun 2021] [Accessed on 06 May 2023], https://d1io3yog0oux5.cloudfront.net/medexusinc/files/pages/medexusinc/db/795/description/Trecondyv+Product+Monograph.pdf
  2. Medac,  [Accessed on 06 May 2023], https://www.ema.europa.eu/en/documents/product-information/trecondi-epar-product-information_en.pdf
  3. International Agency for Research on Cancer; Treosulfan; PHARMACEUTICALS; NCBI Bookshelf; [Revised on 2012] [Accessed:06 May 2023]; https://www.ncbi.nlm.nih.gov/books/NBK304322/#_NBK304322_pubdet_
  4. RA Hilger et al.; Clinical pharmacokinetics of intravenous Treosulfan in patients with advanced solid tumors; [Revised on 1998] [Accessed:06 May 2023] ; https://pubmed.ncbi.nlm.nih.gov/9654108/
  5. GP Breitbach; Treosulfan in the treatment of advanced ovarian cancer: a randomized co-operative multicentre phase-III study; [Revised on 2002] [Accessed:06 May 2023]; https://pubmed.ncbi.nlm.nih.gov/12530019/

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.